Royal Bank Of Canada Portage Biotech Inc. Transaction History

Royal Bank Of Canada

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.21 - $0.55 $31 - $83	152 Added 9.22%	1,801 $0
Q1 2024 Nov 05, 2024	SELL	$0.41 - $1.89 $62 - $287	-152 Reduced 8.44%	1,649 $0
Q1 2024 May 15, 2024	BUY	$0.41 - $1.89 $9 - $41	22 Added 1.35%	1,649 $0
Q4 2023 Feb 14, 2024	SELL	$1.09 - $2.65 $1,533 - $3,728	-1,407 Reduced 46.37%	1,627 $2,000
Q3 2023 Nov 14, 2023	SELL	$2.09 - $3.68 $627 - $1,104	-300 Reduced 9.0%	3,034 $6,000
Q2 2023 Aug 14, 2023	BUY	$2.73 - $3.87 $4,654 - $6,598	1,705 Added 104.67%	3,334 $11,000
Q1 2023 May 15, 2023	SELL	$2.6 - $7.2 $730 - $2,023	-281 Reduced 14.71%	1,629 $5,000
Q4 2022 Feb 14, 2023	BUY	$4.42 - $150.6 $1,272 - $43,372	288 Added 17.76%	1,910 $10,000
Q3 2022 Nov 14, 2022	BUY	$6.81 - $136.4 $762 - $15,276	112 Added 7.42%	1,622 $11,000
Q2 2022 Aug 15, 2022	SELL	$5.16 - $11.95 $1,578 - $3,656	-306 Reduced 16.85%	1,510 $11,000
Q1 2022 May 16, 2022	SELL	$6.57 - $12.0 $5,610 - $10,248	-854 Reduced 31.99%	1,816 $12,000
Q4 2021 Feb 14, 2022	BUY	$10.73 - $23.74 $22,146 - $48,999	2,064 Added 340.59%	2,670 $29,000
Q3 2021 Nov 15, 2021	BUY	$13.65 - $22.4 $8,135 - $13,350	596 Added 5960.0%	606 $13,000
Q2 2021 Aug 16, 2021	BUY	$20.96 - $42.81 $209 - $428	10 New	10 $0

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $87.6M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.